Yongin, South Korea

Sua Lee

This inventor holds 1 USPTO granted patent. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sua Lee. Retrieved from https://idiyas.com/inventor/sua-lee-1k7fzing

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sua Lee: Innovator in Biomedicine

Introduction

Sua Lee is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of biomedicine, particularly through his innovative patent work. His research focuses on developing novel therapeutic approaches that leverage the power of antibodies.

Latest Patents

Sua Lee holds a patent titled "Fusion Protein Comprising Anti-Mesothelin Antibody, Anti-CD3 Antibody or Anti-EGFR Antibody, Bispecific or Trispecific Antibody Comprising Same, and Uses Thereof." This patent represents a significant advancement in targeted therapies, showcasing his expertise in antibody engineering. He has 1 patent to his name, reflecting his commitment to innovation in the biomedical sector.

Career Highlights

Throughout his career, Sua Lee has worked with prominent organizations, including the Green Cross Corporation and the Mogam Institute for Biomedical Research. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Sua Lee has collaborated with notable colleagues, including Jonghwa Won and Shinai Lee. These partnerships have fostered a dynamic research environment, enabling the development of innovative solutions in biomedicine.

Conclusion

In summary, Sua Lee is a distinguished inventor whose work in biomedicine has the potential to impact therapeutic strategies significantly. His innovative approaches and collaborations highlight his dedication to advancing the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…